Clinical Trials Logo

Mass Lesion clinical trials

View clinical trials related to Mass Lesion.

Filter by:
  • None
  • Page 1

NCT ID: NCT06027411 Recruiting - Stroke, Ischemic Clinical Trials

Assess the Clinical Effectiveness in AI Prioritising CT Heads

ACCEPT
Start date: March 27, 2024
Phase:
Study type: Observational [Patient Registry]

Non-Contrast Computed Tomography (NCCT) of the head is the most common imaging method used to assess patients attending the Emergency Department (ED) with a wide range of significant neurological presentations including trauma, stroke, seizure and reduced consciousness. Rapid review of the images supports clinical decision-making including treatment and onward referral. Radiologists, those reporting scans, often have significant backlogs and are unable to prioritise abnormal images of patients with time critical abnormalities. Similarly, identification of normal scans would support patient turnover in ED with significant waits and pressure on resources. To address this problem, Qure.AI has worked to develop the market approved qER algorithm, which is a software program that can analyse CT head to identify presence of abnormalities supporting workflow prioritisation. This study will trial the software in 4 NHS hospitals across the UK to evaluate the ability of the software to reduce the turnaround time of reporting scans with abnormalities that need to be prioritised.

NCT ID: NCT04764396 Terminated - Pancreas Clinical Trials

Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies

Start date: March 12, 2021
Phase: N/A
Study type: Interventional

This is a randomized study that will enroll patients scheduled for an endoscopic ultrasound biopsy of a pancreas lesion to be in the heparin or saline group during the procedure. The purpose of this study is to examine the effect of blood contamination, heparin priming of the fine needle biopsies, and pass number on tumor tissue quality in fine needle biopsies. The hypothesis for this study is that fine needle biopsy tissue quality of pancreatic masses decreases with increasing pass number due to blood contamination; this blood contamination can be ameliorated with priming of the needle with an anticoagulant such as heparin.

NCT ID: NCT03674710 Recruiting - Cancer Clinical Trials

A Multi-center, Prospective, Single-blind, Controlled Trial Comparing Diagnostic Value of Different EUS-FNA Techniques

EUS-FNA
Start date: December 18, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to compare endoscopic ultrasound guided-fine needle aspiration (EUS-FNA) with a standard 22-gauge needle using "standard suction", "slow-pull" and "wet suction" for thoracic/abdominal solid/solid-cystic lesions. Investigators intend to compare the effectiveness and safety of the three methods in order to discover the optimized technique for obtaining diagnostic material and making accurate diagnosis.

NCT ID: NCT02133417 Completed - Mass Lesion Clinical Trials

Non-Inferiority Quantitative Transmission Ultrasound Case Collection Study

QTUS
Start date: July 2014
Phase:
Study type: Observational

Conduct a case collection study of breast imaging examinations from women with mammographically-detected breast lesions for the purpose of conducting subsequent Reader Studies.